Trade Mark Journal No.2026/023 5 June 2026

UK00004380388 29 April 2026 (5,42)

T-Cα

Class 5: Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of autoimmune and infectious diseases.
Class 42: Scientific and technological services and research and design relating thereto; Platform as a service featuring software for machine learning for use in researching, developing, profiling diseases and developing therapeutics; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services.

T-CYPHER BIO LIMITED

Representative: Kilburn & Strode LLP